Position in WVE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,997,649
-$29,877,136 QoQ
Shares Held
965,193
-55.5% QoQ
Ownership
0.490%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WVE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kynam Capital Management, LP holds $1,765,169,848 across 29 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CLDX |
Celldex Therapeutics, Inc.
|
5,322,908 | $198,065,406 | |
| 2 | SNDX |
Syndax Pharmaceuticals Inc
|
8,050,959 | $175,993,963 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
2,922,335 | $169,875,333 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
3,667,097 | $141,916,653 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
2,890,059 | $124,012,431 | |
| 6 | VRDN |
Viridian Therapeutics, Inc.\DE
|
6,453,877 | $118,557,720 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,000,000 | $113,620,000 | |
| 8 | BEAM |
Beam Therapeutics Inc.
|
2,840,792 | $97,495,981 |
All Filings in WVE
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,997,649 | 965,193 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $36,874,785 | 2,169,105 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $33,379,587 | 4,560,053 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $29,640,344 | 4,560,053 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $39,587,935 | 4,899,497 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $60,606,777 | 4,899,497 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $40,175,875 | 4,899,497 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,837,849 | 3,975,521 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $24,260,945 | 3,932,082 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,857,014 | 3,932,082 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $22,609,471 | 3,932,082 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $14,285,551 | 3,924,602 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,488,103 | 3,807,876 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,667,274 | 1,238,182 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,044,899 | 1,397,479 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,514,388 | 1,696,735 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,823,456 | 1,911,728 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,693,025 | 1,494,594 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||